首页> 外国专利> Drugs for diseases associated with increase or decrease in total bile acid pool amount or lipid metabolic diseases, and screening methods for these drugs

Drugs for diseases associated with increase or decrease in total bile acid pool amount or lipid metabolic diseases, and screening methods for these drugs

机译:与总胆汁酸库增加或减少或脂质代谢疾病有关的疾病的药物,以及这些药物的筛选方法

摘要

As a result of creating Gpbar1-deficient mice and examining whether Gpbar1 is involved in the regulation of bile acid homeostasis and lipid metabolism, Gpbar1-deficient mice have a total bile acid pool level without change in fecal bile acid excretion levels. Diminished. In addition, the weight of Gpbar1-deficient female mice bred with high-fat diet significantly increased compared to wild-type mice, which was due to increased fat. This suggests that Gpbar1 contributes to the control of bile acid homeostasis and lipid metabolism.
机译:通过创建Gpbar1缺陷型小鼠并检查Gpbar1是否参与胆汁酸稳态和脂质代谢的调节,Gpbar1缺陷型小鼠的总胆汁酸池水平没有改变粪便胆汁酸排泄水平。减少了。另外,与野生型小鼠相比,高脂饮食喂养的缺乏Gpbar1的雌性小鼠的体重显着增加,这是由于脂肪增加所致。这表明Gpbar1有助于胆汁酸稳态和脂质代谢的控制。

著录项

  • 公开/公告号JPWO2006070718A1

    专利类型

  • 公开/公告日2008-06-12

    原文格式PDF

  • 申请/专利权人 萬有製薬株式会社;

    申请/专利号JP20060550744

  • 申请日2005-12-26

  • 分类号G01N33/50;C12Q1/68;C12Q1/02;A01K67/027;C12N5/10;A61K48;A61K31/713;A61P3/06;A61P43;A61K45;G01N33/15;G01N33/53;G01N33/566;C12N15/09;G01N33/92;

  • 国家 JP

  • 入库时间 2022-08-21 20:17:41

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号